Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_assertion type Assertion NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_head.
- NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_assertion description "[Further in stratified analyses, high miR-221 expression was significantly associated with a poor OS in Asians (pooled HR?=?2.04, P?=?0.010) or serum/ plasma subgroup (pooled HR?=?2.28, P<0.001), and even showed significantly poor OS (pooled HR?=?1.80, P<0.001) and RFS (pooled HR?=?2.43, P?=?0.010) in hepatocellular carcinoma (HCC) subgroup, but was correlated to a favorable RFS in prostate cancer subgroup (pooled HR?=?0.51, P?=?0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_provenance.
- NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_assertion evidence source_evidence_literature NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_provenance.
- NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_assertion SIO_000772 24475314 NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_provenance.
- NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_assertion wasDerivedFrom befree-2016 NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_provenance.
- NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_assertion wasGeneratedBy ECO_0000203 NP1150062.RAHC2oKb5vhcm-CXbpWZoxKlxpmXTVH8ojLgP1kl2iWXk130_provenance.